watch now VIDEO 1:05 01:05 Tom Brady on potential NFL comeback: 'Very happily retired' CNBC Sport Tom Brady may not be returning to the NFL — but he has explored if it's possible. The legendary New England Patriots quarterback, a frequent subject of un-retirement rumors, told CNBC Sport this week that he has asked the NFL about its policy around returning to the league as a player while maintainin...
watch now VIDEO 1:05 01:05 Tom Brady on potential NFL comeback: 'Very happily retired' CNBC Sport Tom Brady may not be returning to the NFL — but he has explored if it's possible. The legendary New England Patriots quarterback, a frequent subject of un-retirement rumors, told CNBC Sport this week that he has asked the NFL about its policy around returning to the league as a player while maintaining his status as a minority owner of the Las Vegas Raiders — but he has no plans to return. "I actually have inquired, and they don't like that idea very much," Brady said in an interview promoting his World Cup ad campaign with Ferrero. "We explored a lot of different things, and I'm very happily retired. Let me just say that, too." An NFL spokesperson said if Brady were to pursue a return to the league, he would first need to divest his ownership stake in the Raiders, citing a 2023 policy that prohibits players or team employees from taking equity in a club. "In addition, there would be salary cap issues involving a player/owner," the spokesperson added . Brady last week participated in a Fanatics flag football game and threw a touchdown pass to wide receiver Stefon Diggs. While Brady acknowledged he loved being back on the field, he said, "if anything, that game reconfirmed to me that I'm very happy in my retirement." Get the CNBC Sport newsletter directly to your inbox The CNBC Sport newsletter with Alex Sherman brings you the biggest news and exclusive interviews from the worlds of sports business and media, delivered weekly to your inbox. Subscribe here to get access today . Brady said since taking a minority stake in the Raiders, he's helped the front office make personnel and coaching decisions in what he called a "strategic advisory role." "I'm a minority owner. So, when you're that, there's really no job description. I don't have really a daily role," he said. "You know, my phone call is always available to everybody who needs it. I want to see everyone succeed, be...
European Commission says social messaging app is exposing children to grooming and sexual exploitation Brussels has opened an investigation into Snapchat over concerns that the social messaging app is exposing children to grooming, sexual exploitation and other criminality. In a separate decision on Thursday, the European Commission also said four pornographic websites were failing to prevent mino...
European Commission says social messaging app is exposing children to grooming and sexual exploitation Brussels has opened an investigation into Snapchat over concerns that the social messaging app is exposing children to grooming, sexual exploitation and other criminality. In a separate decision on Thursday, the European Commission also said four pornographic websites were failing to prevent minors seeing adult content. Continue reading...
ismagilov/iStock via Getty Images KORE Group Holdings, Inc. ( KORE ) is a small-cap IoT (Internet of Things) provider that makes most of its revenues (83%) from providing the actual cellular and satellite links that keep devices online (the IoT Connectivity segment), while the remaining 17% comes from end-to-end device lifecycle management (the IoT Solutions segment). KORE's investor's materials [...
ismagilov/iStock via Getty Images KORE Group Holdings, Inc. ( KORE ) is a small-cap IoT (Internet of Things) provider that makes most of its revenues (83%) from providing the actual cellular and satellite links that keep devices online (the IoT Connectivity segment), while the remaining 17% comes from end-to-end device lifecycle management (the IoT Solutions segment). KORE's investor's materials [ Investor Relations presentation ] The KORE stock surged by ~80% in late February on the news of two private equity firms – Searchlight Capital and Abry Partners – striking a buyout deal at a premium. Based on the terms, KORE shareholders should receive $9.25 per share in cash: Under the terms of the agreement, Searchlight and Abry will acquire all issued and outstanding shares of KORE common stock not already owned by them at an all-cash price of $9.25 per share. The purchase price represents a 691% premium to KORE’s closing share price on Dec. 18, 2024, and a 132% premium to its closing price on Nov. 3, 2025, the last trading days before Searchlight signaled increased investment interest and before it and Abry proposed a $5.00-per-share acquisition, respectively. Source: From Seeking Alpha News The new buyout price per share came in as a major surprise to the market and even some special situations experts: Did not expect an 85% bump to the original $5/shr bid. Over 100% total return since Nov'25. Remaining spread to the $9.25/share bid is just ~3%. One of the most unexpected M&A outcomes I've seen. Source: Dalius [special situations/even-driven analyst] on X As I'm writing these lines, KORE is trading at exactly $9.00 per share, so there's only 2.77% left for those who believe that the firm will be bought out in Q2 or Q3 2026. TrendSpider Software, KORE daily, notes added But why did the PE firms decide to pay so much for KORE? Let's take a look at the company's financials first. In Q3 2025, the latest earnings results report I could find, KORE showed $68.7 million in re...
In this podcast, Motley Fool retirement expert Robert Brokamp and contributor Matt Frankel discuss The Motley Fool’s recent “Best Places to Retire” report as well as: To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center . A full transcript is below. Continue reading
In this podcast, Motley Fool retirement expert Robert Brokamp and contributor Matt Frankel discuss The Motley Fool’s recent “Best Places to Retire” report as well as: To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center . A full transcript is below. Continue reading
Luis Alvarez Stock index futures were lower on Thursday as traders continued to monitor U.S.-Iran developments, with Tehran rejecting an American proposal to end the ongoing conflict. Here are the four stocks to watch on the day: Microsoft ( MSFT ) fell 0.53% in premarket trading after Chief People Officer Amy Coleman announced a reorganization of the human resources team responsible for compensat...
Luis Alvarez Stock index futures were lower on Thursday as traders continued to monitor U.S.-Iran developments, with Tehran rejecting an American proposal to end the ongoing conflict. Here are the four stocks to watch on the day: Microsoft ( MSFT ) fell 0.53% in premarket trading after Chief People Officer Amy Coleman announced a reorganization of the human resources team responsible for compensation and policies. A Microsoft spokesperson confirmed the changes to the HR team, which were first reported by Business Insider. Lumentum ( LITE ) dropped 3.70% before the opening bell after the company announced plans to establish a new manufacturing facility in Greensboro, North Carolina, to produce advanced lasers for the world’s largest AI data centers. The 240,000-square-foot facility is currently operational and will be retrofitted to manufacture Lumentum’s InP-based optical products, including continuous wave and ultra-high-power lasers, with production expected to ramp up in mid-2028. MARA Holdings ( MARA ) gained 6.28% in premarket trade after announcing it had agreed to repurchase approximately $1 billion of its 0% convertible senior notes due 2030 and 2031. The company entered into privately negotiated agreements to repurchase about $367.5 million of its 2030 notes for $322.9 million and ~$633.4 million of its 2031 notes for roughly $589.9 million. Novocure ( NVCR ) advanced 2.15% before the bell after announcing its cancer treatment device, Tumor Treating Fields, reached the primary endpoint in its Phase 2 PANOVA-4 trial for patients with a certain form of pancreatic cancer. The Swiss MedTech company said TTFields, as part of a combination regimen, improved the disease control rate with a statistically significant effect compared to results from its Phase 3 MPACT study, which served as a historical control. More related stories Microsoft: Fortress Balance Sheet, Deep Value Microsoft: I'm Pounding The Table On This Market Misunderstanding Microsoft: Agentic AI May...
Luis Alvarez Stock index futures were lower on Thursday as traders continued to monitor U.S.-Iran developments, with Tehran rejecting an American proposal to end the ongoing conflict. Here are the four stocks to watch on the day: Microsoft ( MSFT ) fell 0.53% in premarket trading after Chief People Officer Amy Coleman announced a reorganization of the human resources team responsible for compensat...
Luis Alvarez Stock index futures were lower on Thursday as traders continued to monitor U.S.-Iran developments, with Tehran rejecting an American proposal to end the ongoing conflict. Here are the four stocks to watch on the day: Microsoft ( MSFT ) fell 0.53% in premarket trading after Chief People Officer Amy Coleman announced a reorganization of the human resources team responsible for compensation and policies. A Microsoft spokesperson confirmed the changes to the HR team, which were first reported by Business Insider. Lumentum ( LITE ) dropped 3.70% before the opening bell after the company announced plans to establish a new manufacturing facility in Greensboro, North Carolina, to produce advanced lasers for the world’s largest AI data centers. The 240,000-square-foot facility is currently operational and will be retrofitted to manufacture Lumentum’s InP-based optical products, including continuous wave and ultra-high-power lasers, with production expected to ramp up in mid-2028. MARA Holdings ( MARA ) gained 6.28% in premarket trade after announcing it had agreed to repurchase approximately $1 billion of its 0% convertible senior notes due 2030 and 2031. The company entered into privately negotiated agreements to repurchase about $367.5 million of its 2030 notes for $322.9 million and ~$633.4 million of its 2031 notes for roughly $589.9 million. Novocure ( NVCR ) advanced 2.15% before the bell after announcing its cancer treatment device, Tumor Treating Fields, reached the primary endpoint in its Phase 2 PANOVA-4 trial for patients with a certain form of pancreatic cancer. The Swiss MedTech company said TTFields, as part of a combination regimen, improved the disease control rate with a statistically significant effect compared to results from its Phase 3 MPACT study, which served as a historical control. More related stories Microsoft: Fortress Balance Sheet, Deep Value Microsoft: I'm Pounding The Table On This Market Misunderstanding Microsoft: Agentic AI May...